US Stock MarketDetailed Quotes

AVDL Avadel Pharmaceuticals

Watchlist
  • 14.060
  • -0.250-1.75%
Close Jun 28 16:00 ET
  • 14.010
  • -0.050-0.36%
Post 18:35 ET
1.35BMarket Cap-7725P/E (TTM)

Avadel Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
27.18M
27.96M
19.45M
7.01M
1.5M
0
0
0
0
0
Operating revenue
--27.18M
--27.96M
--19.45M
--7.01M
--1.5M
--0
--0
--0
--0
--0
Cost of revenue
1.52M
846K
693K
117K
36K
0
0
0
0
0
Gross profit
25.66M
27.12M
18.76M
6.9M
1.46M
0
0
0
0
0
Operating expense
82.67%51.69M
73.25%164.97M
88.06%43.66M
146.68%42.01M
93.59%51M
-1.15%28.3M
11.23%95.22M
0.35%23.22M
-33.64%17.03M
20.10%26.35M
Selling and administrative expenses
98.72%48.62M
103.59%151.71M
143.22%41.3M
177.80%39.16M
114.54%46.78M
13.09%24.47M
8.79%74.52M
-19.24%16.98M
-33.77%14.1M
43.69%21.8M
Research and development costs
-19.90%3.07M
-35.94%13.26M
-62.17%2.36M
-2.86%2.85M
-7.00%4.22M
-45.22%3.83M
21.02%20.7M
195.50%6.24M
-33.04%2.93M
-32.85%4.54M
Operating profit
8.00%-26.04M
-44.78%-137.85M
-7.25%-24.9M
-106.18%-35.11M
-88.05%-49.54M
1.15%-28.3M
-11.23%-95.22M
-0.35%-23.22M
33.64%-17.03M
-20.10%-26.35M
Net non-operating interest income expense
20.47%-2.59M
19.90%-9.89M
27.68%-2.35M
44.50%-1.98M
34.54%-2.3M
-61.58%-3.26M
-24.14%-12.34M
21.64%-3.26M
-84.76%-3.56M
-81.66%-3.51M
Non-operating interest expense
-20.47%2.59M
-19.90%9.89M
-27.68%2.35M
-44.50%1.98M
-34.54%2.3M
61.58%3.26M
24.14%12.34M
-21.64%3.26M
84.76%3.56M
81.66%3.51M
Other net income (expense)
613.99%1.38M
-236.05%-13.04M
-82.55%-1.63M
74.66%903K
-267.82%-12.51M
285.58%193K
-261.98%-3.88M
-238.39%-894K
5.73%517K
-753.85%-3.4M
Gain on sale of security
613.99%1.38M
116.23%87K
-52.24%-1.63M
101.56%903K
224.48%623K
285.58%193K
-122.88%-536K
-232.02%-1.07M
-8.38%448K
-55.56%192K
Special income (charges)
----
-292.50%-13.13M
--0
--0
-265.51%-13.13M
----
-6,411.32%-3.35M
--178K
--69K
---3.59M
-Less:Restructuring and merger&acquisition
----
--0
--0
--0
--0
----
6,411.32%3.35M
---178K
---69K
--3.59M
-Less:Other special charges
----
--13.13M
--0
----
--13.13M
----
----
----
----
----
Income before tax
13.12%-27.25M
-44.27%-160.78M
-5.56%-28.89M
-80.24%-36.19M
-93.50%-64.34M
-2.01%-31.36M
-19.64%-111.44M
-2.71%-27.37M
25.93%-20.08M
-42.43%-33.25M
Income tax
116.03%93K
-101.93%-501K
-217.65%-100K
27.14%89K
-99.70%90K
86.58%-580K
264.55%26.03M
101.96%85K
101.37%70K
901.94%30.19M
Net income
11.18%-27.34M
-16.59%-160.28M
-4.87%-28.79M
-80.06%-36.27M
-1.56%-64.43M
-16.50%-30.78M
-77.77%-137.46M
-23.09%-27.45M
8.44%-20.15M
-224.01%-63.44M
Net income continuous Operations
11.18%-27.34M
-16.59%-160.28M
-4.87%-28.79M
-80.06%-36.27M
-1.56%-64.43M
-16.50%-30.78M
-77.77%-137.46M
-23.09%-27.45M
8.44%-20.15M
-224.01%-63.44M
Minority interest income
Net income attributable to the parent company
11.18%-27.34M
-16.59%-160.28M
-4.87%-28.79M
-80.06%-36.27M
-1.56%-64.43M
-16.50%-30.78M
-77.77%-137.46M
-23.09%-27.45M
8.44%-20.15M
-224.01%-63.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
11.18%-27.34M
-16.59%-160.28M
-4.87%-28.79M
-80.06%-36.27M
-1.56%-64.43M
-16.50%-30.78M
-77.77%-137.46M
-23.09%-27.45M
8.44%-20.15M
-224.01%-63.44M
Basic earnings per share
37.50%-0.3
12.66%-2
34.09%-0.29
-24.24%-0.41
22.43%-0.83
-6.67%-0.48
-73.48%-2.29
-15.79%-0.44
13.16%-0.33
-224.24%-1.07
Diluted earnings per share
37.50%-0.3
12.66%-2
34.09%-0.29
-24.24%-0.41
22.43%-0.83
-6.67%-0.48
-73.48%-2.29
-15.79%-0.44
13.16%-0.33
-224.24%-1.07
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 27.18M27.96M19.45M7.01M1.5M00000
Operating revenue --27.18M--27.96M--19.45M--7.01M--1.5M--0--0--0--0--0
Cost of revenue 1.52M846K693K117K36K00000
Gross profit 25.66M27.12M18.76M6.9M1.46M00000
Operating expense 82.67%51.69M73.25%164.97M88.06%43.66M146.68%42.01M93.59%51M-1.15%28.3M11.23%95.22M0.35%23.22M-33.64%17.03M20.10%26.35M
Selling and administrative expenses 98.72%48.62M103.59%151.71M143.22%41.3M177.80%39.16M114.54%46.78M13.09%24.47M8.79%74.52M-19.24%16.98M-33.77%14.1M43.69%21.8M
Research and development costs -19.90%3.07M-35.94%13.26M-62.17%2.36M-2.86%2.85M-7.00%4.22M-45.22%3.83M21.02%20.7M195.50%6.24M-33.04%2.93M-32.85%4.54M
Operating profit 8.00%-26.04M-44.78%-137.85M-7.25%-24.9M-106.18%-35.11M-88.05%-49.54M1.15%-28.3M-11.23%-95.22M-0.35%-23.22M33.64%-17.03M-20.10%-26.35M
Net non-operating interest income expense 20.47%-2.59M19.90%-9.89M27.68%-2.35M44.50%-1.98M34.54%-2.3M-61.58%-3.26M-24.14%-12.34M21.64%-3.26M-84.76%-3.56M-81.66%-3.51M
Non-operating interest expense -20.47%2.59M-19.90%9.89M-27.68%2.35M-44.50%1.98M-34.54%2.3M61.58%3.26M24.14%12.34M-21.64%3.26M84.76%3.56M81.66%3.51M
Other net income (expense) 613.99%1.38M-236.05%-13.04M-82.55%-1.63M74.66%903K-267.82%-12.51M285.58%193K-261.98%-3.88M-238.39%-894K5.73%517K-753.85%-3.4M
Gain on sale of security 613.99%1.38M116.23%87K-52.24%-1.63M101.56%903K224.48%623K285.58%193K-122.88%-536K-232.02%-1.07M-8.38%448K-55.56%192K
Special income (charges) -----292.50%-13.13M--0--0-265.51%-13.13M-----6,411.32%-3.35M--178K--69K---3.59M
-Less:Restructuring and merger&acquisition ------0--0--0--0----6,411.32%3.35M---178K---69K--3.59M
-Less:Other special charges ------13.13M--0------13.13M--------------------
Income before tax 13.12%-27.25M-44.27%-160.78M-5.56%-28.89M-80.24%-36.19M-93.50%-64.34M-2.01%-31.36M-19.64%-111.44M-2.71%-27.37M25.93%-20.08M-42.43%-33.25M
Income tax 116.03%93K-101.93%-501K-217.65%-100K27.14%89K-99.70%90K86.58%-580K264.55%26.03M101.96%85K101.37%70K901.94%30.19M
Net income 11.18%-27.34M-16.59%-160.28M-4.87%-28.79M-80.06%-36.27M-1.56%-64.43M-16.50%-30.78M-77.77%-137.46M-23.09%-27.45M8.44%-20.15M-224.01%-63.44M
Net income continuous Operations 11.18%-27.34M-16.59%-160.28M-4.87%-28.79M-80.06%-36.27M-1.56%-64.43M-16.50%-30.78M-77.77%-137.46M-23.09%-27.45M8.44%-20.15M-224.01%-63.44M
Minority interest income
Net income attributable to the parent company 11.18%-27.34M-16.59%-160.28M-4.87%-28.79M-80.06%-36.27M-1.56%-64.43M-16.50%-30.78M-77.77%-137.46M-23.09%-27.45M8.44%-20.15M-224.01%-63.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 11.18%-27.34M-16.59%-160.28M-4.87%-28.79M-80.06%-36.27M-1.56%-64.43M-16.50%-30.78M-77.77%-137.46M-23.09%-27.45M8.44%-20.15M-224.01%-63.44M
Basic earnings per share 37.50%-0.312.66%-234.09%-0.29-24.24%-0.4122.43%-0.83-6.67%-0.48-73.48%-2.29-15.79%-0.4413.16%-0.33-224.24%-1.07
Diluted earnings per share 37.50%-0.312.66%-234.09%-0.29-24.24%-0.4122.43%-0.83-6.67%-0.48-73.48%-2.29-15.79%-0.4413.16%-0.33-224.24%-1.07
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg